How white is your smile?

Biolase (NASDAQ:BIOL) released its earnings results on Wednesday. The medical technology company reported ($0.04) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.04), Bloomberg Earnings reports. Biolase had a negative return on equity of 67.04% and a negative …

See the full post >